Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Insect Biochemistry and Molecular Biology|September 8, 2004
Dynamic of ligand binding to Drosophila melanogaster ecdysteroid receptorMarco Grebe, Torsten Fauth, Margarethe Spindler-Barth
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 17, 2021
Cell Volume Regulation in the EpidermisMagdalena Jahn, Oliver Rauh, Torsten Fauth, et al.
JID Innovations : Skin Science From Molecules to Population Health|June 10, 2025
The Volume-Regulated Anion Channel LRRC8 is Involved in the Initiation of Epidermal Differentiation and is Deregulated in PsoriasisMagdalena Jahn, Victoria Lang, Oliver Rauh, et al.
Nucleic Acids Research|February 9, 2010
The DNA binding CXC domain of MSL2 is required for faithful targeting the Dosage Compensation Complex to the X chromosomeTorsten Fauth, Felix Müller-Planitz, Cornelia König, et al.
Experimental Dermatology|December 3, 2023
Different immortalized keratinocyte cell lines display distinct capabilities to differentiate and reconstitute an epidermis in vitroMagdalena Jahn, Victoria Lang, Sandra Diehl, et al.
Nucleic Acids Research|May 8, 2007
Cumulative contributions of weak DNA determinants to targeting the Drosophila dosage compensation complexGregor D Gilfillan, Cornelia König, Ina K Dahlsveen, et al.
Cell Calcium|March 18, 2023
The Ca2+ channel TRPV4 is dispensable for Ca2+ influx and cell volume regulation during hypotonic stress response in human keratinocyte cell linesDirk Ritzmann, Magdalena Jahn, Susanne Heck, et al.
Cancers|October 13, 2021
Profiling Cisplatin Resistance in Head and Neck Cancer: A Critical Role of the VRAC Ion Channel for ChemoresistanceSvenja Siemer, Torsten Fauth, Paul Scholz, et al.
ACS Nano|November 5, 2021
Targeting Cancer Chemotherapy Resistance by Precision Medicine-Driven Nanoparticle-Formulated CisplatinSvenja Siemer, Tobias A Bauer, Paul Scholz, et al.
Nature|May 6, 2026
RNA-triggered cell killing with CRISPR-Cas12a2Paul Scholz, Jared Thompson, Kadin T Crosby, et al.
Pageof 1